
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Engineered CRISPR-Cas9 nucleases with altered PAM specificities
Benjamin P. Kleinstiver, Michelle S. Prew, Shengdar Q. Tsai, et al.
Nature (2015) Vol. 523, Iss. 7561, pp. 481-485
Open Access | Times Cited: 1529
Benjamin P. Kleinstiver, Michelle S. Prew, Shengdar Q. Tsai, et al.
Nature (2015) Vol. 523, Iss. 7561, pp. 481-485
Open Access | Times Cited: 1529
Showing 1-25 of 1529 citing articles:
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Alexis C. Komor, Y. Bill Kim, Michael S. Packer, et al.
Nature (2016) Vol. 533, Iss. 7603, pp. 420-424
Open Access | Times Cited: 4521
Alexis C. Komor, Y. Bill Kim, Michael S. Packer, et al.
Nature (2016) Vol. 533, Iss. 7603, pp. 420-424
Open Access | Times Cited: 4521
High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
Benjamin P. Kleinstiver, Vikram Pattanayak, Michelle S. Prew, et al.
Nature (2016) Vol. 529, Iss. 7587, pp. 490-495
Open Access | Times Cited: 2393
Benjamin P. Kleinstiver, Vikram Pattanayak, Michelle S. Prew, et al.
Nature (2016) Vol. 529, Iss. 7587, pp. 490-495
Open Access | Times Cited: 2393
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
Andrew V. Anzalone, Luke W. Koblan, David R. Liu
Nature Biotechnology (2020) Vol. 38, Iss. 7, pp. 824-844
Closed Access | Times Cited: 1809
Andrew V. Anzalone, Luke W. Koblan, David R. Liu
Nature Biotechnology (2020) Vol. 38, Iss. 7, pp. 824-844
Closed Access | Times Cited: 1809
CRISPR–Cas9 Structures and Mechanisms
Fuguo Jiang, Jennifer A. Doudna
Annual Review of Biophysics (2017) Vol. 46, Iss. 1, pp. 505-529
Open Access | Times Cited: 1732
Fuguo Jiang, Jennifer A. Doudna
Annual Review of Biophysics (2017) Vol. 46, Iss. 1, pp. 505-529
Open Access | Times Cited: 1732
The CRISPR tool kit for genome editing and beyond
Mazhar Adli
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 1460
Mazhar Adli
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 1460
Evolved Cas9 variants with broad PAM compatibility and high DNA specificity
Johnny H. Hu, Shannon M. Miller, Maarten H. Geurts, et al.
Nature (2018) Vol. 556, Iss. 7699, pp. 57-63
Open Access | Times Cited: 1391
Johnny H. Hu, Shannon M. Miller, Maarten H. Geurts, et al.
Nature (2018) Vol. 556, Iss. 7699, pp. 57-63
Open Access | Times Cited: 1391
Base editing: precision chemistry on the genome and transcriptome of living cells
Holly A. Rees, David R. Liu
Nature Reviews Genetics (2018) Vol. 19, Iss. 12, pp. 770-788
Open Access | Times Cited: 1361
Holly A. Rees, David R. Liu
Nature Reviews Genetics (2018) Vol. 19, Iss. 12, pp. 770-788
Open Access | Times Cited: 1361
CRISPR/Cas Genome Editing and Precision Plant Breeding in Agriculture
Kunling Chen, Yanpeng Wang, Rui Zhang, et al.
Annual Review of Plant Biology (2019) Vol. 70, Iss. 1, pp. 667-697
Open Access | Times Cited: 1255
Kunling Chen, Yanpeng Wang, Rui Zhang, et al.
Annual Review of Plant Biology (2019) Vol. 70, Iss. 1, pp. 667-697
Open Access | Times Cited: 1255
The next generation of CRISPR–Cas technologies and applications
Adrian Pickar‐Oliver, Charles A. Gersbach
Nature Reviews Molecular Cell Biology (2019) Vol. 20, Iss. 8, pp. 490-507
Open Access | Times Cited: 1242
Adrian Pickar‐Oliver, Charles A. Gersbach
Nature Reviews Molecular Cell Biology (2019) Vol. 20, Iss. 8, pp. 490-507
Open Access | Times Cited: 1242
Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
Xiaohui Zhang, Louis Y. Tee, Xiaogang Wang, et al.
Molecular Therapy — Nucleic Acids (2015) Vol. 4, pp. e264-e264
Open Access | Times Cited: 1125
Xiaohui Zhang, Louis Y. Tee, Xiaogang Wang, et al.
Molecular Therapy — Nucleic Acids (2015) Vol. 4, pp. e264-e264
Open Access | Times Cited: 1125
CRISPR/Cas9 in Genome Editing and Beyond
Haifeng Wang, Marie La Russa, Lei S. Qi
Annual Review of Biochemistry (2016) Vol. 85, Iss. 1, pp. 227-264
Open Access | Times Cited: 1069
Haifeng Wang, Marie La Russa, Lei S. Qi
Annual Review of Biochemistry (2016) Vol. 85, Iss. 1, pp. 227-264
Open Access | Times Cited: 1069
Enhanced proofreading governs CRISPR–Cas9 targeting accuracy
Janice S. Chen, Yavuz S. Dagdas, Benjamin P. Kleinstiver, et al.
Nature (2017) Vol. 550, Iss. 7676, pp. 407-410
Open Access | Times Cited: 1031
Janice S. Chen, Yavuz S. Dagdas, Benjamin P. Kleinstiver, et al.
Nature (2017) Vol. 550, Iss. 7676, pp. 407-410
Open Access | Times Cited: 1031
Delivering CRISPR: a review of the challenges and approaches
Christopher A. Lino, Jason C. Harper, James P. Carney, et al.
Drug Delivery (2018) Vol. 25, Iss. 1, pp. 1234-1257
Open Access | Times Cited: 995
Christopher A. Lino, Jason C. Harper, James P. Carney, et al.
Drug Delivery (2018) Vol. 25, Iss. 1, pp. 1234-1257
Open Access | Times Cited: 995
Engineered CRISPR-Cas9 nuclease with expanded targeting space
Hiroshi Nishimasu, Xi Shi, Soh Ishiguro, et al.
Science (2018) Vol. 361, Iss. 6408, pp. 1259-1262
Open Access | Times Cited: 973
Hiroshi Nishimasu, Xi Shi, Soh Ishiguro, et al.
Science (2018) Vol. 361, Iss. 6408, pp. 1259-1262
Open Access | Times Cited: 973
Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants
Russell T. Walton, Kathleen A. Christie, Madelynn N. Whittaker, et al.
Science (2020) Vol. 368, Iss. 6488, pp. 290-296
Open Access | Times Cited: 965
Russell T. Walton, Kathleen A. Christie, Madelynn N. Whittaker, et al.
Science (2020) Vol. 368, Iss. 6488, pp. 290-296
Open Access | Times Cited: 965
CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering
Kornel Labun, Tessa G. Montague, James A. Gagnon, et al.
Nucleic Acids Research (2016) Vol. 44, Iss. W1, pp. W272-W276
Open Access | Times Cited: 935
Kornel Labun, Tessa G. Montague, James A. Gagnon, et al.
Nucleic Acids Research (2016) Vol. 44, Iss. W1, pp. W272-W276
Open Access | Times Cited: 935
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
Alexis C. Komor, Ahmed H. Badran, David R. Liu
Cell (2016) Vol. 168, Iss. 1-2, pp. 20-36
Open Access | Times Cited: 931
Alexis C. Komor, Ahmed H. Badran, David R. Liu
Cell (2016) Vol. 168, Iss. 1-2, pp. 20-36
Open Access | Times Cited: 931
Applications of CRISPR technologies in research and beyond
Rodolphe Barrangou, Jennifer A. Doudna
Nature Biotechnology (2016) Vol. 34, Iss. 9, pp. 933-941
Closed Access | Times Cited: 878
Rodolphe Barrangou, Jennifer A. Doudna
Nature Biotechnology (2016) Vol. 34, Iss. 9, pp. 933-941
Closed Access | Times Cited: 878
Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9
Dominik Paquet, Dylan Kwart, Chen Antonia, et al.
Nature (2016) Vol. 533, Iss. 7601, pp. 125-129
Closed Access | Times Cited: 851
Dominik Paquet, Dylan Kwart, Chen Antonia, et al.
Nature (2016) Vol. 533, Iss. 7601, pp. 125-129
Closed Access | Times Cited: 851
Drug delivery systems for RNA therapeutics
Kalina Paunovska, David Loughrey, James E. Dahlman
Nature Reviews Genetics (2022) Vol. 23, Iss. 5, pp. 265-280
Open Access | Times Cited: 832
Kalina Paunovska, David Loughrey, James E. Dahlman
Nature Reviews Genetics (2022) Vol. 23, Iss. 5, pp. 265-280
Open Access | Times Cited: 832
BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
Matthew C. Canver, Elenoe C. Smith, Falak Sher, et al.
Nature (2015) Vol. 527, Iss. 7577, pp. 192-197
Open Access | Times Cited: 826
Matthew C. Canver, Elenoe C. Smith, Falak Sher, et al.
Nature (2015) Vol. 527, Iss. 7577, pp. 192-197
Open Access | Times Cited: 826
Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions
Y. Bill Kim, Alexis C. Komor, Jonathan M. Levy, et al.
Nature Biotechnology (2017) Vol. 35, Iss. 4, pp. 371-376
Open Access | Times Cited: 714
Y. Bill Kim, Alexis C. Komor, Jonathan M. Levy, et al.
Nature Biotechnology (2017) Vol. 35, Iss. 4, pp. 371-376
Open Access | Times Cited: 714
Whole-organism lineage tracing by combinatorial and cumulative genome editing
Aaron McKenna, Gregory M. Findlay, James A. Gagnon, et al.
Science (2016) Vol. 353, Iss. 6298
Open Access | Times Cited: 704
Aaron McKenna, Gregory M. Findlay, James A. Gagnon, et al.
Science (2016) Vol. 353, Iss. 6298
Open Access | Times Cited: 704
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
Christopher A. Vakulskas, Daniel P. Dever, Garrett R. Rettig, et al.
Nature Medicine (2018) Vol. 24, Iss. 8, pp. 1216-1224
Open Access | Times Cited: 689
Christopher A. Vakulskas, Daniel P. Dever, Garrett R. Rettig, et al.
Nature Medicine (2018) Vol. 24, Iss. 8, pp. 1216-1224
Open Access | Times Cited: 689
Genome-editing Technologies for Gene and Cell Therapy
Morgan L. Maeder, Charles A. Gersbach
Molecular Therapy (2016) Vol. 24, Iss. 3, pp. 430-446
Open Access | Times Cited: 671
Morgan L. Maeder, Charles A. Gersbach
Molecular Therapy (2016) Vol. 24, Iss. 3, pp. 430-446
Open Access | Times Cited: 671